iifl-logo
  • testing
  • |

iifl-logo

Strides Pharma Science Ltd Annually Results

819.75
(3.22%)
Jun 10, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Mar-2025Mar-2024Mar-2023Mar-2022Mar-2021

Gross Sales

4,565.34

3,890.13

3,688.39

3,070.25

3,315.87

Excise Duty

0

0

0

0

0

Net Sales

4,565.34

3,890.13

3,688.39

3,070.25

3,315.87

Other Operating Income

0

0

0

0

0

Other Income

3,313.33

89.29

108.9

131.99

108.72

Total Income

7,878.66

3,979.42

3,797.28

3,202.24

3,424.59

Total Expenditure

3,762.52

3,550.76

3,560.52

3,444.99

2,778.86

PBIDT

4,116.14

428.66

236.76

-242.76

645.73

Interest

248.85

280.22

261.14

176.74

150.07

PBDT

3,867.29

148.44

-24.38

-419.5

495.67

Depreciation

192.26

213.64

243.25

233.01

206.29

Minority Interest Before NP

0

0

0

0

0

Tax

46.91

32.37

-31.7

-150.44

21.45

Deferred Tax

30.61

-3.26

-23.6

-27.82

10.2

Reported Profit After Tax

3,597.51

-94.32

-212.33

-474.25

257.73

Minority Interest After NP

4.06

-23.7

-9.7

-14.04

-10.71

Net Profit after Minority Interest

3,593.46

-70.62

-202.64

-460.21

268.44

Extra-ordinary Items

3,242.47

-107.08

1.54

-243.83

38.37

Adjusted Profit After Extra-ordinary item

350.99

36.46

-204.18

-216.38

230.07

EPS (Unit Curr.)

390.54

-7.76

-22.49

-51.28

29.96

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

40

25

15

0

25

Equity

92.16

91.9

90.3

89.79

89.68

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

90.16

11.01

6.41

-7.9

19.47

PBDTM(%)

84.7

3.81

-0.66

-13.66

14.94

PATM(%)

78.8

-2.42

-5.75

-15.44

7.77

Strides Pharma: Related NEWS

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

testing
  • testing
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

testing
  • testing
  • testing

ATTENTION INVESTOR

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.